It looks like you're offline.
Donate
English (en) Change Website Language
Open Library logo
additional options menu
Last edited by MARC Bot
April 26, 2022 | History
Edit

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen

We need a photo of Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen

14 works Add another?

Showing all works by author. Would you like to see only ebooks?

  • Cover of: Verfahren zur Lungenvolumenreduktion beim schweren Lungenemphysem

    First published in 2017 — 1 edition
    Locate

    My Reading Lists:

    Create a new list

    Check-In

    ×Close
    Add an optional check-in date. Check-in dates are used to track yearly reading goals.
    Today
  • Cover of: Lonoctocog alfa (Hämophilie A): Nutzenbewertung gemäß § 35a SGB V

    First published in 2017 — 1 edition
    Locate

    My Reading Lists:

    Create a new list

    Check-In

    ×Close
    Add an optional check-in date. Check-in dates are used to track yearly reading goals.
    Today
  • Cover of: Leitliniensynopse für ein DMP Depressionen

    First published in 2017 — 1 edition
    Locate

    My Reading Lists:

    Create a new list

    Check-In

    ×Close
    Add an optional check-in date. Check-in dates are used to track yearly reading goals.
    Today
  • Cover of: Vandetanib (Schilddrüsenkarzinom): Nutzenbewertung gemäß § 35a SGB V

    First published in 2017 — 1 edition
    Locate

    My Reading Lists:

    Create a new list

    Check-In

    ×Close
    Add an optional check-in date. Check-in dates are used to track yearly reading goals.
    Today
  • Cover of: Obeticholsäure (primäre biliäre Cholangitis): Bewertung gemäß § 35a Abs. 1 Satz 10 SGB V

    First published in 2017 — 1 edition
    Locate

    My Reading Lists:

    Create a new list

    Check-In

    ×Close
    Add an optional check-in date. Check-in dates are used to track yearly reading goals.
    Today
  • Cover of: Ixazomib (multiples Myelom): Bewertung gemäß § 35a Abs. 1 Satz 10 SGB V

    First published in 2017 — 1 edition
    Locate

    My Reading Lists:

    Create a new list

    Check-In

    ×Close
    Add an optional check-in date. Check-in dates are used to track yearly reading goals.
    Today
  • Cover of: Reslizumab (Asthma): Nutzenbewertung gemäß § 35a SGB V

    First published in 2017 — 1 edition
    Locate

    My Reading Lists:

    Create a new list

    Check-In

    ×Close
    Add an optional check-in date. Check-in dates are used to track yearly reading goals.
    Today
  • Cover of: Aktive Kniebewegungsschienen in der Behandlung von Rupturen des vorderen Kreuzbands

    First published in 2017 — 1 edition
    Locate

    My Reading Lists:

    Create a new list

    Check-In

    ×Close
    Add an optional check-in date. Check-in dates are used to track yearly reading goals.
    Today
  • Cover of: Cabozantinib (Nierenzellkarzinom): Addendum zum Auftrag A16-69

    First published in 2017 — 1 edition
    Locate

    My Reading Lists:

    Create a new list

    Check-In

    ×Close
    Add an optional check-in date. Check-in dates are used to track yearly reading goals.
    Today
  • Cover of: Pembrolizumab (nicht kleinzelliges Lungenkarzinom: Nutzenbewertung gemäß § 35a SGB V

    First published in 2017 — 1 edition
    Locate

    My Reading Lists:

    Create a new list

    Check-In

    ×Close
    Add an optional check-in date. Check-in dates are used to track yearly reading goals.
    Today
  • Cover of: Palbociclib (Mammakarzinom): Addendum zum Auftrag A16-74

    First published in 2017 — 1 edition
    Locate

    My Reading Lists:

    Create a new list

    Check-In

    ×Close
    Add an optional check-in date. Check-in dates are used to track yearly reading goals.
    Today
  • Cover of: Extrakorporale Stoßwellentherapie beim Fersenschmerz

    First published in 2017 — 1 edition
    Locate

    My Reading Lists:

    Create a new list

    Check-In

    ×Close
    Add an optional check-in date. Check-in dates are used to track yearly reading goals.
    Today
  • Cover of: Secukinumab(Plaque-Psoriasis): Nutzenbewertung gemäß § 35a SGB V (neue wissenschaftliche Erkenntnisse)

    First published in 2017 — 1 edition
    Locate

    My Reading Lists:

    Create a new list

    Check-In

    ×Close
    Add an optional check-in date. Check-in dates are used to track yearly reading goals.
    Today
  • Cover of: Ixekizumab (Plaque Psoriasis): Nutzenbewertung gemäß § 35a SGB V

    First published in 2017 — 1 edition
    Locate

    My Reading Lists:

    Create a new list

    Check-In

    ×Close
    Add an optional check-in date. Check-in dates are used to track yearly reading goals.
    Today
We need a photo of Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen

Subjects

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, Bewertung, Krebs, Nutzen, Onkologie, Deutschland, Deutschland Gemeinsamer Bundesausschuss, Atemnot, Atemwegskrankheit, Auftrag, Dermatologie, Hautkrankheit, Zusatznutzen, Bronchialasthma, Cholangitis, Cisplatin, Extrakorporale Stoßwellenlithotripsie, Hypernephrom, Hämophilie A, Kardiovaskuläre Krankheit, Kniegelenk, Krankheit, Ligamentum cruciatum anterius, Lungenemphysem, Lungenkrebs

Lists

Add to List

My Reading Lists:

Create a new list

ID Numbers

  • OLID: OL10351335A

Links outside Open Library

No links yet. Add one?

History

Download catalog record: RDF / JSON
April 26, 2022 Created by MARC Bot import new book